51,410 results on '"tacrolimus"'
Search Results
2. A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
3. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy (MAJESTY)
4. Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
5. Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
6. JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
7. Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
8. Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
9. Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
10. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
11. 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
12. Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
13. Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
14. Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
15. Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
16. Expanding Liver Transplant Immunosuppression Minimization Via Everolimus (ELIMINATE)
17. Belatacept in Heart Transplantation
18. Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
19. Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients with Myelodysplastic Syndrome or Acute Leukemia
20. Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
21. BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
22. Itacitinib for the Prevention of Graft Versus Host Disease
23. A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (AQUA)
24. Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus
25. Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation. (BRUNO-PIC)
26. Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
27. A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
28. Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
29. Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
30. Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
31. Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) (STRIDE2)
32. Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.
33. Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
34. A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy
35. HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis (OPTIMIZE)
36. Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™ (OPERATOR)
37. Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients (LTA)
38. Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
39. Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
40. Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
41. MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
42. Off-the-shelf NK Cells + SCT for Myeloid Malignancies
43. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
44. Evaluating LP-10 in Subjects With OLP
45. REgulatory T Cell Therapy to Achieve Immunosuppression REduction (RETIRE)
46. Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients
47. CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
48. Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study
49. Uterus Transplantation to Treat Infertility (OPRTUNTI)
50. Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.